TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Bionor AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
4,880
|
4,607
|
3,301 |
| Financial expenses |
2
|
3
|
4 |
| Earnings before taxes |
282
|
293
|
-122 |
| EBITDA |
285
|
295
|
-120 |
| Total assets |
1,468
|
1,240
|
1,220 |
| Current assets |
1,468
|
1,240
|
1,220 |
| Current liabilities |
268
|
277
|
437 |
| Equity capital |
1,199
|
963
|
659 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
81.7%
|
77.7%
|
54.0% |
| Turnover per employee |
4,880
|
4,607
|
3,301 |
| Profit as a percentage of turnover |
5.8%
|
6.4%
|
-3.7% |
| Return on assets (ROA) |
19.3%
|
23.9%
|
-9.7% |
| Current ratio |
547.8%
|
447.7%
|
279.2% |
| Return on equity (ROE) |
23.5%
|
30.4%
|
-18.5% |
| Change turnover |
190
|
1,072
|
-162 |
| Change turnover % |
4%
|
30%
|
-5% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.